Treatment of conditions involving demyelination
US8486893B2 · kind B2 · utility
6Cited by
71References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 24, 2005 |
| Grant date | Jul 16, 2013 |
| Priority date | — |
| Expiry date | May 22, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods of treating diseases, disorsers or injuries involving demyelination and dysmyelination, including multiple sclerosis, by the administration of an Sp35 antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.